Financhill
Back

SPDR S&P Telecom ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

XTL
SPDR S&P Telecom ETF

Last Price:
$101.05
Seasonality Move:
-0.74%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Sell
45
SPDR S&P Telecom ETF (XTL) is a Sell

Is SPDR S&P Telecom ETF a Buy, Sell or Hold?

  • The current SPDR S&P Telecom ETF [XTL] share price is $100.94. The Score for XTL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • XTL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XTL Stock Price Chart

What is SPDR S&P Telecom ETF's stock price today?

  • The SPDR S&P Telecom ETF share price today is $100.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

XTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 34.71 Sell
Chaikin Money Flow: 9115 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (105.53 - 111.91) Sell
Bollinger Bands (100): (103.99 - 110.67) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.87 - 112.63) Sell
Bollinger Bands (100): (110.05 - 127.23) Sell

XTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 108.34 Sell
50-day SMA: 108.28 Sell
200-day SMA: 96.89 Buy
8-day EMA: 104.91 Sell
20-day EMA: 106.95 Sell
50-day EMA: 107.69 Sell
200-day EMA: 98.76 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

SPDR S&P Telecom ETF Earnings Growth & XTL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

SPDR S&P Telecom ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):